首页> 美国卫生研究院文献>British Journal of Cancer >Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer
【2h】

Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer

机译:胃癌中肿瘤浸润淋巴细胞的类型和密度对预后的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The study aims to determine whether type and density of tumour-infiltrating lymphocytes (TILs) can predict the clinical course in gastric cancer. Gastric carcinomas (n=220) were immunostained for CD3, CD8, CD20, and CD45RO and evaluated for clinicopathologic characteristics. Number of TILs that immunostained positively for each marker were counted using NIH ImageJ software. Tumours were grouped into low- and high-density groups for each marker (CD3, CD8, CD45RO). The densities of CD3+, CD8+, and CD45RO+ TILs were found to be independent predictors of lymph node metastasis by multivariate analysis with odds ratios (95% CI) of 0.425 (0.204–0.885), 0.325 (0.150–0.707), and 0.402 (0.190–0.850), respectively. Kaplan–Meier survival analysis revealed that patients in the high-density groups for CD3, CD8, and C45RO had a significantly longer survival time than the patients in the corresponding low-density groups, respectively. In multivariate survival analysis, the densities of CD3+, CD8+, and CD45RO+ TILs remained independent prognostic factors with hazard ratios (95% CI) of 0.549 (0.317–0.951), 0.574 (0.347–0.949), and 0.507 (0.298–0.862), respectively. In conclusion, density of TILs was found to be independently predictive of regional lymph node metastasis and patient survival in gastric cancer.
机译:该研究旨在确定肿瘤浸润淋巴细胞(TIL)的类型和密度是否可以预测胃癌的临床病程。对胃癌(n = 220)进行CD3,CD8,CD20和CD45RO免疫染色,并评估其临床病理特征。使用NIH ImageJ软件对每种标记阳性免疫染色的TIL数量进行计数。对于每种标记(CD3,CD8,CD45RO),将肿瘤分为低密度和高密度组。通过比值比进行多变量分析,发现CD3 + ,CD8 + 和CD45RO + TILs的密度是淋巴结转移的独立预测因子。 (95%CI)分别为0.425(0.204-0.885),0.325(0.150-0.707)和0.402(0.190-0.850)。 Kaplan-Meier生存分析表明,高密度CD3,CD8和C45RO组的患者的生存时间分别比相应的低密度组的患者长得多。在多因素生存分析中,CD3 + ,CD8 + 和CD45RO + TIL的密度仍是独立的预后因素,危险比(95%CI )分别为0.549(0.317-0.951),0.574(0.347-0.949)和0.507(0.298-0.862)。总之,发现TILs的密度可独立预测胃癌的区域淋巴结转移和患者生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号